Identity & Authority: Alpecin โ€“ Signal Evidence & AI Readability

Alpecin

(https://alpecin.com) ๐Ÿ“ธ Data Snapshot: May 29, 2026
Identity & Authority โ€” The Lens

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Identity & Authority Expert verifiability & Schema depth.
11 Impact Weight: 15 / 100
73% Reputation

The company names Dr. Erik Schulze zur Wiesche as the Head of Research and Development, which provides a human face to the scientific claims. However, there is no Person schema or sameAs links to professional profiles like LinkedIn or ORCID to verify his digital academic footprint in the provided structured data. The authority is primarily institutional rather than personal, relying on the heritage of the Dr. Wolff Group without modern structured identity proof for its lead scientists.

The boldest claim, ‘strongest doping for your hair,’ is clearly framed as a metaphor for growth stimulation rather than a medical promise of a cure. Unlike generic competitors, Alpecin attempts to bridge the performance gap by citing a double-blind, randomized study conducted in Rome with 154 participants. The technical specification that scalp micro-circulation is reduced to less than 40% in affected areas provides a measurable physiological baseline for their product claims.

Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.

๐Ÿ”— Identity & Technical Layer โ€” schema JSON-LD: identity chains, entity gaps
Homepage โ€” no schema detected (entity gap)
/en-int/ โ€” no schema detected (entity gap)
/ar-ae/ โ€” no schema detected (entity gap)
/en-de/
{
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
        {
            "@type": "Question",
            "name": "Sources",
            "acceptedAnswer": {
                "@type": "Answer",
                "text": "ยน C. Bussoletti, F. Mastropietro, M. V. Tolaini, L. Celleno (2010): Use of a caffeine shampoo for the treatment of male androgenetic alopecia. Journal of Applied Cosmetology. 28,4 (Oct. 2010), 153-162. ยฒ Dhurat R, Chitallia J, May TW, Jayaraaman AM, Madhukara J, Anandan S, Vaidya P, Klenk A. (2017): An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia. Skin Pharmacol Physiol. ;30(6):298-305. ยณ Otberg N, Teichmann A, Rasuljev U, Sinkgraven R, Sterry W, Lademann J (2007): Follicular penetration of topically applied caffeine via a shampoo formulation. Skin Pharmacol Physiol.;20(4):195-8."
            }
        }
    ]
}
๐Ÿ›ก๏ธ Trust Signals โ€” external proof links that back the declared identity
1128Review mentions (all pages)
4External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
/en-int/ 644 0
/ar-ae/ 0 2
/en-de/ 484 2